Prof. Dr. med. Jürgen Siebler

Professur für Hepatologie

A Phase 2 Study of Galunisertib (TGF-beta 1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (2019) Kelley RK, Gane E, Assenat E, Galle PR, Merle P, Hourmand IO, Cleverly A, et al. Journal article Comparison of Hemospray (R) and Endoclot (TM) for the treatment of gastrointestinal bleeding (2019) Vitali F, Naegel A, Atreya R, Zopf S, Neufert C, Neurath M, Rath T, Siebler J Journal article Correction to: Influence of cancer and acute inflammatory disease on taste perception: a clinical pilot study (2019) Schalk P, Kohl M, Herrmann HJ, Schwappacher R, Rimmele ME, Büttner A, Neurath M, et al. Journal article, Erratum Comparison of Hemospray® and Endoclot™ for the treatment of gastrointestinal bleeding (2019) Vitali F, Naegel A, Atreya R, Zopf S, Neufert C, Neurath M, Rath T, Siebler J Journal article Influence of cancer and acute inflammatory disease on taste perception: a clinical pilot study (2018) Schalk P, Kohl M, Herrmann HJ, Schwappacher R, Rimmele M, Büttner A, Neurath M, et al. Journal article Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial (2018) Schink K, Herrmann HJ, Schwappacher R, Meyer J, Orlemann T, Waldmann E, Wullich B, et al. Journal article EFFICACY OF HEMOSPRAY AND ENDOCLOT IN THE TREATMENT OF GASTROINTESTINAL BLEEDING: RESULTS FROM A TERTIARY REFFERAL CENTER (2018) Vitali F, Naegel A, Neurath M, Rath T, Siebler J Conference contribution ENDOSCOPIC FULL-THICKNESS RESECTION IN THE COLORECTUM USING THE FTRD: RESULTS FROM A UNIVERSITY TERTIARY REFERRAL CENTER (2018) Vitali F, Naegel A, Neurath M, Rath T, Siebler J Conference contribution I-scan optical enhancement for the in vivo prediction of diminutive colorectal polyp histology: Results from a prospective three-phased multicentre trial (2018) Klenske E, Zopf S, Neufert C, Naegel A, Gschossmann J, Muehldorfer S, Pfeifer L, et al. Journal article Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN (2018) Schlichtig K, Lechner P, Grafe C, Ferstl B, Fuchs F, Hein A, Meidenbauer N, et al. Conference contribution